Insulin action and type 2 diabetes: Lessons from knockout mice

Current Opinion in Endocrinology and Diabetes

Volumn 6, Issue 2, 1999, Pages 141-145

  Withers, Dominic J ^a   White, Morris F ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADIPOSE TISSUE; ARTICLE; CELL FUNCTION; DIABETOGENESIS; GLUCOSE METABOLISM; INSULIN RELEASE; INSULIN RESISTANCE; MOUSE; MUSCLE TISSUE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS CELL; SIGNAL TRANSDUCTION;

EID: 0033043821     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-199904000-00010     Document Type: Article

References (19)

1. 1 Myers MG, Jr., White MF. Insulin signal transduction and the IRS proteins. Annu Rev Pharmacol Toxicol 1996, 36:615-658.
2. 2 Sun XJ, Rothenberg PL, Kahn CR, Backer JM, Araki E, Wilden PA, Cahill DA, Goldstein BJ, White MF. The structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 1991, 352:73-77.
3. 3 Sun XJ, Wang LM, Zhang Y, Yenush L, Myers MG, Jr., Glasheen EM, Lane WS, Pierce JH, White MF. Role of IRS-2 in insulin and cytokine signalling. Nature 1995, 377:173-177.
4. 4 Lavan BE, Lane WS, Lienhard GE. The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family. J Biol Chem 1997, 272:11439-11443.
5. 5 Lavan BE, Fantin VR, Chang ET, Lane WS, Keller SR, Lienhard GE. A novel 160 kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family. J Biol Chem 272:21403-21407.
6. 6 Shepherd PR, Withers DJ, Siddle K. Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochem J 1998, 333:471-490.
7. 7 Araki E, Lipes MA, Patti ME, Brüning JC, Haag BL, III, Johnson RS, Kahn CR. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 1994, 372:186-190.
8. 8 Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, Hayakawa T, Terauchi Y, Ueki K, Kaburagi Y, Satoh S, Sekihara H, Yoshioka S, Horikoshi H, Furuta Y, Ikawa Y, Kasuga M, Yazaki Y, Aizawa S. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 1994, 372:182-186.
9. 9 Yamauchi T, Tobe K, Tamemoto H, Ueki K, Kaburagi Y, Yamamoto-Handa R, Takahadhi Y, Yoshizawa F, Aizawa S, Akanuma Y, Sonenberg N, Yazaki Y, Kadowaki T. Insulin signaling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice. Mol Cell Biol 1996, 16:3074-3084.
10. 10 Withers DJ, Sanchez-Gutierrez JC, Towery H, Ren JM, Burks DJ, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, White MF. Disruption of IRS 2 causes type 2 diabetes in mice. Nature 1998, 391:900-903. Disruption of IRS-2 causes both defects in insulin action in liver and muscle and also attenuates the beta-cell compensatory response to insulin resistance with the result that mice develop type 2 diabetes.
11. 11 Rother KI, Imai Y, Caruso M, Beguinot F, Formisano P, Accili D. Evidence that IRS-2 phosphorylation is required for insulin action in hepatocytes. J Biol Chem 1998, 273:17491-17497.
12. 12 Sander M, German MS. The β-cell transcription factors and development of the pancreas. J Mol Med 1997, 75:327-340.
13. 13 Leibiger IB, Leibiger B, Moede T, Berggren PO. Exocytosis of insulin promotes insulin gene transcription via the insulin receptor/PI-3 kinase/p70 s6 kinase and CaM kinase. Mol Cell 1998, 1:933-938. Insulin regulates the transcription of the insulin gene via the IRS-2 dependent signaling pathway.
14. 14 Xu GG, Rothenberg PL. Insulin receptor signaling in the β-cell influences insulin gene expression and insulin content. Diabetes 1998, 47:1243-1252.
15. 15 Hugl SR, White MF, Rhodes CJ. IGF-1 stimulated pancreatic β-cell growth is glucose dependent: Synergistic activation of IRS-mediated signal transduction pathways by glucose and IGF-1 in INS-1 cells. J Biol Chem 1998, 272:17771-17779.
16. 16 Kulkarni, RN, Bruning, JC, Winnay JN, Postic C, Magnuson MA, Kahn CR. Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in Type 2 diabetes. Cell 1999, 96:329-339. Beta cell specific deletion of the insulin receptor results in a first phase insulin secretory defect that resembles that seen in type 2 diabetes.
17. 17 DeFronzo RA. Pathogenesis of type 2 diabetes: Metabolic and molecular implications for identifying diabetes genes. Diabetes Rev 1997, 5:177-269.
18. 18 Bruning JC, Michael MD, Winnay JN, Hayashi T, Horsch D, Accili D, Goodyear LJ, Kahn CR. A muscle specific insulin receptor knockout challenges the current concepts of glucose disposal and NIDDM pathogenesis. Mol Cell 1998, 2:569. Muscle specific deletion of the insulin receptor attenuates insulin signaling and action in muscle but does not result in diabetes.
19. 19 Laura, D., Kido, Y., Hayashi, H., Ebina, Y., and Accili, D. Transgenic knockout mice with a targeted impairment of insulin action in skeletal muscle and adipose tissue. Nature Genetics 1998, 20:294-298. Attenuation of insulin signaling in muscle and adipose tissue does not cause diabetes.